Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-10-01

AUTHORS

H Veelken, R Wäsch, D Behringer, H Bertz, J Finke

ABSTRACT

Conditioning regimens with reduced intensity are used increasingly for allogeneic stem cell transplantation in elderly or extensively pretreated patients. Two cases of pure red cell aplasia after fludarabine-based conditioning and during immunosuppression with cyclosporin are described. Both patients received AB0-mismatched stem cells and had anti-donor isoagglutinins. Red cell recovery occurred after extended immunosuppression when isoagglutinins had disappeared. Colony assays indicated serologic suppression of the erythrocyte lineage in one patient. Since reduced conditioning permits donor cell engraftment primarily by suppression of host T cells, antibody-mediated immunological complications may occur more frequently than after ‘classical’ conditioning. Bone Marrow Transplantation (2000) 26, 911–915. More... »

PAGES

911-915

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bmt.1702629

DOI

http://dx.doi.org/10.1038/sj.bmt.1702629

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001197168

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11081395


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ABO Blood-Group System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppression Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Red-Cell Aplasia, Pure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation Conditioning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Homologous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7708.8", 
          "name": [
            "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Veelken", 
        "givenName": "H", 
        "id": "sg:person.01270675225.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270675225.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7708.8", 
          "name": [
            "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "W\u00e4sch", 
        "givenName": "R", 
        "id": "sg:person.01151333006.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151333006.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7708.8", 
          "name": [
            "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Behringer", 
        "givenName": "D", 
        "id": "sg:person.01014243716.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014243716.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7708.8", 
          "name": [
            "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bertz", 
        "givenName": "H", 
        "id": "sg:person.01356464223.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356464223.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7708.8", 
          "name": [
            "Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Finke", 
        "givenName": "J", 
        "id": "sg:person.015025432322.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015025432322.94"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1702512", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046870598", 
          "https://doi.org/10.1038/sj.bmt.1702512"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-10-01", 
    "datePublishedReg": "2000-10-01", 
    "description": "Conditioning regimens with reduced intensity are used increasingly for allogeneic stem cell transplantation in elderly or extensively pretreated patients. Two cases of pure red cell aplasia after fludarabine-based conditioning and during immunosuppression with cyclosporin are described. Both patients received AB0-mismatched stem cells and had anti-donor isoagglutinins. Red cell recovery occurred after extended immunosuppression when isoagglutinins had disappeared. Colony assays indicated serologic suppression of the erythrocyte lineage in one patient. Since reduced conditioning permits donor cell engraftment primarily by suppression of host T cells, antibody-mediated immunological complications may occur more frequently than after \u2018classical\u2019 conditioning. Bone Marrow Transplantation (2000) 26, 911\u2013915.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bmt.1702629", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "allogeneic stem cell transplantation", 
      "pure red cell aplasia", 
      "stem cell transplantation", 
      "red cell aplasia", 
      "cell transplantation", 
      "cell aplasia", 
      "host T cells", 
      "donor cell engraftment", 
      "red cell recovery", 
      "extended immunosuppression", 
      "immunological complications", 
      "T cells", 
      "cell engraftment", 
      "patients", 
      "colony assay", 
      "immunosuppression", 
      "cell recovery", 
      "transplantation", 
      "aplasia", 
      "stem cells", 
      "isoagglutinins", 
      "erythrocyte lineage", 
      "reduced intensity", 
      "cells", 
      "fludarabine", 
      "complications", 
      "engraftment", 
      "suppression", 
      "cyclosporin", 
      "conditioning", 
      "assays", 
      "AB0", 
      "cases", 
      "recovery", 
      "lineages", 
      "intensity"
    ], 
    "name": "Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning", 
    "pagination": "911-915", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001197168"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bmt.1702629"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11081395"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bmt.1702629", 
      "https://app.dimensions.ai/details/publication/pub.1001197168"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_339.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bmt.1702629"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702629'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702629'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702629'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702629'


 

This table displays all metadata directly associated to this object as RDF triples.

173 TRIPLES      21 PREDICATES      73 URIs      64 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bmt.1702629 schema:about N076ac77ac97547be9373338c8992f561
2 N32c1eccf590e46d7a501d0699041de72
3 N40198810304a43ef83a0ae7e80116ddb
4 N47f8c13bf36949a4b4797560b2e62e63
5 N4b3358c8079044499ebe2b305c9c259e
6 N56dd0ae645844765a1f9ee2adb62a470
7 N8615b5e1d7f248a496f57d89c47b5d95
8 N8d2b0c32a0cb4961b6189913b3a7257d
9 Na2c737cee00d4273be0cc1eb67a4f12b
10 Nc96cd09da8b74e009d018f284f6bd30c
11 Ne9c4213d4d0f480fa96f59fff0457afa
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author N24558c8d4327463e927c2db70acaabcc
15 schema:citation sg:pub.10.1038/sj.bmt.1702512
16 schema:datePublished 2000-10-01
17 schema:datePublishedReg 2000-10-01
18 schema:description Conditioning regimens with reduced intensity are used increasingly for allogeneic stem cell transplantation in elderly or extensively pretreated patients. Two cases of pure red cell aplasia after fludarabine-based conditioning and during immunosuppression with cyclosporin are described. Both patients received AB0-mismatched stem cells and had anti-donor isoagglutinins. Red cell recovery occurred after extended immunosuppression when isoagglutinins had disappeared. Colony assays indicated serologic suppression of the erythrocyte lineage in one patient. Since reduced conditioning permits donor cell engraftment primarily by suppression of host T cells, antibody-mediated immunological complications may occur more frequently than after ‘classical’ conditioning. Bone Marrow Transplantation (2000) 26, 911–915.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf N211bccb4b3f947a1b8b3d7d8fb67a69e
22 Nca01766cb83a4d42aad399b13e5c4dc2
23 sg:journal.1096890
24 schema:keywords AB0
25 T cells
26 allogeneic stem cell transplantation
27 aplasia
28 assays
29 cases
30 cell aplasia
31 cell engraftment
32 cell recovery
33 cell transplantation
34 cells
35 colony assay
36 complications
37 conditioning
38 cyclosporin
39 donor cell engraftment
40 engraftment
41 erythrocyte lineage
42 extended immunosuppression
43 fludarabine
44 host T cells
45 immunological complications
46 immunosuppression
47 intensity
48 isoagglutinins
49 lineages
50 patients
51 pure red cell aplasia
52 recovery
53 red cell aplasia
54 red cell recovery
55 reduced intensity
56 stem cell transplantation
57 stem cells
58 suppression
59 transplantation
60 schema:name Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning
61 schema:pagination 911-915
62 schema:productId N8d8134b2c4df45c28e68c0c07bd65881
63 N8d8e88faee314d058d387f7c936d3e23
64 N8e026421049c4ccb922902b7c118ab13
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001197168
66 https://doi.org/10.1038/sj.bmt.1702629
67 schema:sdDatePublished 2022-10-01T06:31
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher Nef4c75410a2e478ebcd4ffe81c10c8b1
70 schema:url https://doi.org/10.1038/sj.bmt.1702629
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N076ac77ac97547be9373338c8992f561 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Humans
76 rdf:type schema:DefinedTerm
77 N211bccb4b3f947a1b8b3d7d8fb67a69e schema:issueNumber 8
78 rdf:type schema:PublicationIssue
79 N24558c8d4327463e927c2db70acaabcc rdf:first sg:person.01270675225.37
80 rdf:rest Ncfb9c9c7c2ad40f1a12458b4d2c9e8e3
81 N2daf0f340ba1413aa92af74221213643 rdf:first sg:person.015025432322.94
82 rdf:rest rdf:nil
83 N2f0c3563d83a426ab339aece5461d652 rdf:first sg:person.01356464223.06
84 rdf:rest N2daf0f340ba1413aa92af74221213643
85 N32c1eccf590e46d7a501d0699041de72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Transplantation Conditioning
87 rdf:type schema:DefinedTerm
88 N40198810304a43ef83a0ae7e80116ddb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Red-Cell Aplasia, Pure
90 rdf:type schema:DefinedTerm
91 N47f8c13bf36949a4b4797560b2e62e63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Immunosuppression Therapy
93 rdf:type schema:DefinedTerm
94 N4b3358c8079044499ebe2b305c9c259e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Transplantation, Homologous
96 rdf:type schema:DefinedTerm
97 N56dd0ae645844765a1f9ee2adb62a470 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Middle Aged
99 rdf:type schema:DefinedTerm
100 N7b05c57f391547a4ac79604cee5a21be rdf:first sg:person.01014243716.90
101 rdf:rest N2f0c3563d83a426ab339aece5461d652
102 N8615b5e1d7f248a496f57d89c47b5d95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Female
104 rdf:type schema:DefinedTerm
105 N8d2b0c32a0cb4961b6189913b3a7257d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Adult
107 rdf:type schema:DefinedTerm
108 N8d8134b2c4df45c28e68c0c07bd65881 schema:name dimensions_id
109 schema:value pub.1001197168
110 rdf:type schema:PropertyValue
111 N8d8e88faee314d058d387f7c936d3e23 schema:name doi
112 schema:value 10.1038/sj.bmt.1702629
113 rdf:type schema:PropertyValue
114 N8e026421049c4ccb922902b7c118ab13 schema:name pubmed_id
115 schema:value 11081395
116 rdf:type schema:PropertyValue
117 Na2c737cee00d4273be0cc1eb67a4f12b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Graft vs Host Disease
119 rdf:type schema:DefinedTerm
120 Nc96cd09da8b74e009d018f284f6bd30c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Hematopoietic Stem Cell Transplantation
122 rdf:type schema:DefinedTerm
123 Nca01766cb83a4d42aad399b13e5c4dc2 schema:volumeNumber 26
124 rdf:type schema:PublicationVolume
125 Ncfb9c9c7c2ad40f1a12458b4d2c9e8e3 rdf:first sg:person.01151333006.25
126 rdf:rest N7b05c57f391547a4ac79604cee5a21be
127 Ne9c4213d4d0f480fa96f59fff0457afa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name ABO Blood-Group System
129 rdf:type schema:DefinedTerm
130 Nef4c75410a2e478ebcd4ffe81c10c8b1 schema:name Springer Nature - SN SciGraph project
131 rdf:type schema:Organization
132 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
133 schema:name Medical and Health Sciences
134 rdf:type schema:DefinedTerm
135 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
136 schema:name Clinical Sciences
137 rdf:type schema:DefinedTerm
138 sg:journal.1096890 schema:issn 0268-3369
139 1476-5365
140 schema:name Bone Marrow Transplantation
141 schema:publisher Springer Nature
142 rdf:type schema:Periodical
143 sg:person.01014243716.90 schema:affiliation grid-institutes:grid.7708.8
144 schema:familyName Behringer
145 schema:givenName D
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014243716.90
147 rdf:type schema:Person
148 sg:person.01151333006.25 schema:affiliation grid-institutes:grid.7708.8
149 schema:familyName Wäsch
150 schema:givenName R
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151333006.25
152 rdf:type schema:Person
153 sg:person.01270675225.37 schema:affiliation grid-institutes:grid.7708.8
154 schema:familyName Veelken
155 schema:givenName H
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270675225.37
157 rdf:type schema:Person
158 sg:person.01356464223.06 schema:affiliation grid-institutes:grid.7708.8
159 schema:familyName Bertz
160 schema:givenName H
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356464223.06
162 rdf:type schema:Person
163 sg:person.015025432322.94 schema:affiliation grid-institutes:grid.7708.8
164 schema:familyName Finke
165 schema:givenName J
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015025432322.94
167 rdf:type schema:Person
168 sg:pub.10.1038/sj.bmt.1702512 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046870598
169 https://doi.org/10.1038/sj.bmt.1702512
170 rdf:type schema:CreativeWork
171 grid-institutes:grid.7708.8 schema:alternateName Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany
172 schema:name Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany
173 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...